Targeted Liposomal Drug Delivery in Cancer
Journal:
Current Pharmaceutical Design
Volume:
10
Page:
2981-2989
Author(s):
Oula Penate Medina, Ying Zhu and Kalevi Kairemo
Nerve Growth Factor Receptors and Signaling in Breast Cancer
Journal:
Current Cancer Drug Targets
Volume:
4
Page:
463-470
Author(s):
Laurent Dolle, Eric Adriaenssens, Ikram El Yazidi-Belkoura, Xuefen Le Bourhis, Victor Nurcombe and Hubert Hondermarck
Heparin Affin Regulatory Peptide: A New Target for Tumour Therapy?
Journal:
Current Cancer Drug Targets
Volume:
4
Page:
471-482
Author(s):
E. Papadimitriou, A. Polykratis, M. Hatziapostolou, A. Parthymou, C. Polytarchou and C. Mikelis
Pituitary Adenylate Cyclase Activating Polypeptide: A Potential Neuroprotective Peptide
Journal:
Current Pharmaceutical Design
Volume:
10
Page:
2861-2889
Author(s):
Aniko Somogyvari-Vigh and Dora Reglodi
Combining Gene Therapy and Radiation Against Cancer
Journal:
Current Gene Therapy
Volume:
4
Page:
231-248
Author(s):
Daila S. Gridley and James M. Slater
Cancer Gene Therapy through Autonomous Parvovirus - Mediated Gene Transfer
Journal:
Current Gene Therapy
Volume:
4
Page:
249-261
Author(s):
Jan J. Cornelis, Susanne I. Lang, Alexandra Y. Stroh-Dege, Ginette Balboni, Christiane Dinsart and Jean Rommelaere
Undermining Tumor Angiogenesis by Gene Therapy: An Emerging Field
Journal:
Current Gene Therapy
Volume:
4
Page:
297-308
Author(s):
S. Indraccolo
The Anandamide Degradation System as Potential Target for the Treatment of Central Nervous System Related Disorders
Journal:
Current Medicinal Chemistry - Central Nervous System Agents
Volume:
4
Page:
155-160
Author(s):
Maria L Lopez-Rodriguez and Silvia Ortega-Gutierrez
Metabolism of the Endocannabinoids Anandamide and 2-Arachidonoyl Glycerol, A Review, with Emphasis on the Pharmacology of Fatty Acid Amide Hydrolase, A Possible Target for the Treatment of Neurodegenerative Diseases and Pain
Journal:
Current Medicinal Chemistry - Central Nervous System Agents
Volume:
4
Page:
161-174
Author(s):
Christopher J. Fowler
Melanocortin Receptor Type 3 as a Potential Target for Anti-Inflammatory Therapy
Journal:
Current Drug Targets - Inflammation & Allergy
Volume:
3
Page:
311-315
Author(s):
Connie W. Lam and Stephen J. Getting